DGX vs. JNJ
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or JNJ.
Correlation
The correlation between DGX and JNJ is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DGX vs. JNJ - Performance Comparison
Key characteristics
DGX:
1.33
JNJ:
0.35
DGX:
2.15
JNJ:
0.60
DGX:
1.26
JNJ:
1.08
DGX:
1.65
JNJ:
0.38
DGX:
8.08
JNJ:
1.07
DGX:
3.67%
JNJ:
6.21%
DGX:
22.34%
JNJ:
19.11%
DGX:
-49.46%
JNJ:
-52.60%
DGX:
-1.32%
JNJ:
-9.20%
Fundamentals
DGX:
$19.69B
JNJ:
$373.36B
DGX:
$7.91
JNJ:
$9.00
DGX:
22.23
JNJ:
17.21
DGX:
1.57
JNJ:
1.06
DGX:
1.94
JNJ:
4.18
DGX:
2.81
JNJ:
5.24
DGX:
$10.16B
JNJ:
$89.33B
DGX:
$3.31B
JNJ:
$61.01B
DGX:
$1.81B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, DGX achieves a 16.31% return, which is significantly higher than JNJ's 7.74% return. Over the past 10 years, DGX has outperformed JNJ with an annualized return of 11.26%, while JNJ has yielded a comparatively lower 7.32% annualized return.
DGX
16.31%
4.80%
13.17%
30.91%
12.60%
11.26%
JNJ
7.74%
-4.42%
-2.37%
8.66%
2.82%
7.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. JNJ — Risk-Adjusted Performance Rank
DGX
JNJ
DGX vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DGX vs. JNJ - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.76%, less than JNJ's 3.21% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.76% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
JNJ Johnson & Johnson | 3.21% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
DGX vs. JNJ - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for DGX and JNJ. For additional features, visit the drawdowns tool.
Volatility
DGX vs. JNJ - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 9.76%, while Johnson & Johnson (JNJ) has a volatility of 10.88%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DGX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities